MCLA-158 (petosemtamab), an IgG1 bispecific antibody targeting EGFR and LGR5, in advanced gastric/esophageal adenocarcinoma (GEA)CANCER RESEARCHIF16.62023-04-141PRE
The Effect of Ibuprofen Exposure and Patient Characteristics on the Closure of the Patent Ductus Arteriosus in Preterm InfantsCLINICAL PHARMACOLOGY & THERAPEUTICSIF5.52022-05-067OAAI
The bioavailability and maturing clearance of doxapram in preterm infantsPEDIATRIC RESEARCHIF3.12020-07-2210OAAI
Enantiomer specific pharmacokinetics of ibuprofen in preterm neonates with patent ductus arteriosusBRITISH JOURNAL OF CLINICAL PHARMACOLOGYIF32020-04-2015OAAI